摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-1-(4-aminophenyl)-3-(benzo[d][1,3]dioxol-5-yl)prop-2-en-1-one | 873934-58-8

中文名称
——
中文别名
——
英文名称
(E)-1-(4-aminophenyl)-3-(benzo[d][1,3]dioxol-5-yl)prop-2-en-1-one
英文别名
(E)-3-(1,3-benzodioxol-5-yl)-1-(4-aminophenyl)-2-propen-1-one;(E)-1-(4-aminophenyl)-3-(1,3-benzodioxol-5-yl)prop-2-en-1-one
(E)-1-(4-aminophenyl)-3-(benzo[d][1,3]dioxol-5-yl)prop-2-en-1-one化学式
CAS
873934-58-8
化学式
C16H13NO3
mdl
——
分子量
267.284
InChiKey
HRRYLMJOPQRTKQ-LREOWRDNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    199 °C(Solv: ethanol (64-17-5); water (7732-18-5))
  • 沸点:
    486.7±45.0 °C(Predicted)
  • 密度:
    1.314±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    61.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (E)-1-(4-aminophenyl)-3-(benzo[d][1,3]dioxol-5-yl)prop-2-en-1-one溴乙酰溴potassium carbonate 作用下, 生成 N-[4-[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]phenyl]-2-bromoacetamide
    参考文献:
    名称:
    Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: Synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity
    摘要:
    A group of novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids was prepared. One-dose anticancer test results indicated that compounds 3a and 3g exhibited the highest ability to inhibit the proliferation of different cancer cell lines. Compound 3a exhibited a broad-spectrum of anti-tumor activity without pronounced selectivity while compound 3g revealed high selectivity toward the leukemia subpanel with selectivity ratio of 6.71 at GI(50) level. Moreover, compounds 3e and 3j have shown remarkable topo II inhibitory activity compared to etoposide at 100 gI A and 20 mu M concentrations. Compounds 3e and 3j exhibited comparably potent topo I inhibitory activity at 20 RM concentration compared to camptothecin. Compounds 3e and 3j exhibited strong topo II inhibitory activities compared to topo I at 20 laM concentration. Studying of the solubility and partition coefficient revealed higher lipophilicity of the hybrids 3a j compared to the parent ciprofloxacin. (C) 2013 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2013.08.040
  • 作为产物:
    描述:
    胡椒醛4-氨基苯乙酮 在 sodium hydroxide 作用下, 以 neat (no solvent) 为溶剂, 反应 0.08h, 以95%的产率得到(E)-1-(4-aminophenyl)-3-(benzo[d][1,3]dioxol-5-yl)prop-2-en-1-one
    参考文献:
    名称:
    环保型胡椒醛的合成及其细胞毒性和抗氧化性评价
    摘要:
    背景:磨石技术已被广泛用作一种高效,一致,对环境无害且无溶剂的方案,用于制备许多具有更高原子经济性的化合物。 方法:通过该方法合成了14种胡椒醛查耳酮化合物,并通过物理和光谱数据(FT-IR,1H NMR,质量和元素分析)进行了表征。评估所有查耳酮对癌细胞系MCF-7和HepG2的细胞毒性作用。一种2-吡啶基取代的化合物14,对MCF-7的IC50值为17.4±0.2,对HepG2细胞的IC50值为15.4±0.6µmol L-1。 结果:结果表明,与标准的顺铂相比,2-吡啶基取代的化合物对HepG2细胞具有更高的细胞毒活性。 结论:与标准抗坏血酸(IC50 = µg / mL,18.26±0.22)相比,化合物14在DPPH测试和H2O2分析中显示出良好的抗氧化活性(IC50 = 17.23±33 / µg / mL和20.17±0.33µg / mL)。 21.66±1.06 µg /
    DOI:
    10.2174/1570180815666181016155934
点击查看最新优质反应信息

文献信息

  • Synthesis and cdc25B inhibitory activity evaluation of chalcones
    作者:Fei Zhao、Qing-Jie Zhao、Jing-Xia Zhao、Da-Zhi Zhang、Qiu-Ye Wu、Yong-Sheng Jin
    DOI:10.1007/s10600-013-0563-7
    日期:2013.5
    A library of sixty-five chalcones was prepared for screening against the protein phosphatase, cdc25B. From this library, thirteen compounds were found having good inhibitory activity. Two compounds have excellent activity and can be used for the design of more potent antiproliferative agents.
    制备了一个包含六十五种查尔酮的库,用于针对蛋白磷酸酶cdc25B进行筛选。从这个库中,发现了十三种具有良好抑制活性的化合物。其中两种化合物表现出极佳的活性,可用于设计更有效的抗增殖剂。
  • An Environment-friendly Synthesis of Piperonal Chalcones and Their Cytotoxic and Antioxidant Evaluation
    作者:Sanal Dev、Della Grace Thomas Parambi、Bency Baby、Githa Elizabeth Mathew、Hendawy Omnia Magdy、Monu Joy、Shine Sudev、Bijo Mathew
    DOI:10.2174/1570180815666181016155934
    日期:2020.2.13
    elemental analysis). All chalcones were evaluated for their cytotoxic action against the cancer cell lines, MCF-7 and HepG2. One 2-pyridyl-substituted compound 14 with IC50 values 17.4±0.2 towards MCF-7 and 15.4±0.6µmol L-1 towards HepG2 cells. Results: The results demonstrated that the cytotoxic activity of 2-pyridyl-substituted compound shown higher activity as compared with the standard cisplatin
    背景:磨石技术已被广泛用作一种高效,一致,对环境无害且无溶剂的方案,用于制备许多具有更高原子经济性的化合物。 方法:通过该方法合成了14种胡椒醛查耳酮化合物,并通过物理和光谱数据(FT-IR,1H NMR,质量和元素分析)进行了表征。评估所有查耳酮对癌细胞系MCF-7和HepG2的细胞毒性作用。一种2-吡啶基取代的化合物14,对MCF-7的IC50值为17.4±0.2,对HepG2细胞的IC50值为15.4±0.6µmol L-1。 结果:结果表明,与标准的顺铂相比,2-吡啶基取代的化合物对HepG2细胞具有更高的细胞毒活性。 结论:与标准抗坏血酸(IC50 = µg / mL,18.26±0.22)相比,化合物14在DPPH测试和H2O2分析中显示出良好的抗氧化活性(IC50 = 17.23±33 / µg / mL和20.17±0.33µg / mL)。 21.66±1.06 µg /
  • Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: Synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity
    作者:Mohamed Abdel-Aziz、So-Eun Park、Gamal El-Din A.A. Abuo-Rahma、Mohamed A. Sayed、Youngjoo Kwon
    DOI:10.1016/j.ejmech.2013.08.040
    日期:2013.11
    A group of novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids was prepared. One-dose anticancer test results indicated that compounds 3a and 3g exhibited the highest ability to inhibit the proliferation of different cancer cell lines. Compound 3a exhibited a broad-spectrum of anti-tumor activity without pronounced selectivity while compound 3g revealed high selectivity toward the leukemia subpanel with selectivity ratio of 6.71 at GI(50) level. Moreover, compounds 3e and 3j have shown remarkable topo II inhibitory activity compared to etoposide at 100 gI A and 20 mu M concentrations. Compounds 3e and 3j exhibited comparably potent topo I inhibitory activity at 20 RM concentration compared to camptothecin. Compounds 3e and 3j exhibited strong topo II inhibitory activities compared to topo I at 20 laM concentration. Studying of the solubility and partition coefficient revealed higher lipophilicity of the hybrids 3a j compared to the parent ciprofloxacin. (C) 2013 Elsevier Masson SAS. All rights reserved.
查看更多